AIP insider filing: CEO reports RSU tax sale and 10b5-1 trades

Rhea-AI Filing Summary

Arteris (AIP) — Form 4 insider activity: President and CEO K. Charles Janac, who is also a Director and 10% Owner, reported open‑market sales on 10/02/2025 and 10/03/2025. The filing lists sales of 2,767, 1,613, and 2,767 shares at $10.9208, and a separate sale of 11,821 shares at a weighted average price of $11.0705 (with individual trades between $10.80 and $11.29).

One set of shares was sold to satisfy the reporting person’s tax liability from an RSU release, and another transaction was made under a Rule 10b5‑1 trading plan adopted on March 5, 2025. Following the reported transactions, direct holdings were shown as 167,514 shares. Indirect holdings were listed as 9,839,071 shares through Bayview Legacy, LLC and 56,252 shares held by the Charles and Lydia Janac Trust.

Insights

Governance & Insider Transactions Analyst

Routine insider sales tied to RSU taxes and a 10b5‑1 plan.

The reported sales include trades on 10/02/2025 at $10.9208 and on 10/03/2025 at a weighted average of $11.0705, with the latter spanning $10.80–$11.29. Footnotes state one sale covered tax liability from an RSU release, while another followed a Rule 10b5‑1 plan adopted on March 5, 2025.

Post‑trade positions remain substantial: 167,514 shares direct, plus 9,839,071 via Bayview Legacy, LLC and 56,252 in the Charles and Lydia Janac Trust. These figures indicate continued significant exposure by the executive.

Given the administrative nature (tax withholding and pre‑set plan), the signaling value is limited. Actual impact depends on ongoing disclosures in future filings.

SEC Form 4

FORM 4

UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940

OMB APPROVAL

OMB Number:			3235-0287
Estimated average burden
hours per response:			0.5

Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).

X

Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.

1. Name and Address of Reporting Person^*

JANAC K CHARLES

(Last) (First) (Middle)

C/O ARTERIS, INC.

900 E. HAMILTON AVE., SUITE 300

(Street)

CAMPBELL CA 95008

(City) (State) (Zip)

2. Issuer Name and Ticker or Trading Symbol
Arteris, Inc. [ AIP ]

5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)

X	Director	X	10% Owner
X	Officer (give title below)		Other (specify below)
	President and CEO

3. Date of Earliest Transaction (Month/Day/Year)
10/02/2025

4. If Amendment, Date of Original Filed (Month/Day/Year)

6. Individual or Joint/Group Filing (Check Applicable Line)

X	Form filed by One Reporting Person
	Form filed by More than One Reporting Person

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3)	2. Transaction Date (Month/Day/Year)	2A. Deemed Execution Date, if any (Month/Day/Year)	3. Transaction Code (Instr. 8)		4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5)			5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4)	6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	7. Nature of Indirect Beneficial Ownership (Instr. 4)
			Code	V	Amount	(A) or (D)	Price
Common Stock	10/02/2025		S(1)		2,767	D	$10.9208	183,715	D
Common Stock	10/02/2025		S(1)		1,613	D	$10.9208	182,102	D
Common Stock	10/02/2025		S(1)		2,767	D	$10.9208	179,335	D
Common Stock	10/03/2025		S(2)		11,821	D	$11.0705(3)	167,514	D
Common Stock								9,839,071	I	Bayview Legacy, LLC(4)
Common Stock								56,252	I	Charles and Lydia Janac Trust(5)

Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3)	2. Conversion or Exercise Price of Derivative Security	3. Transaction Date (Month/Day/Year)	3A. Deemed Execution Date, if any (Month/Day/Year)	4. Transaction Code (Instr. 8)		5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5)		6. Date Exercisable and Expiration Date (Month/Day/Year)		7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4)		8. Price of Derivative Security (Instr. 5)	9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4)	10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	11. Nature of Indirect Beneficial Ownership (Instr. 4)
				Code	V	(A)	(D)	Date Exercisable	Expiration Date	Title	Amount or Number of Shares

Explanation of Responses:

1. Shares sold to satisfy the Reporting Person's tax liability arising as a result of the release of restricted stock units.

2. Transaction made pursuant to a 10b5-1 trading plan that was adopted by the Reporting Person on March 5, 2025.

3. The price reported in Column 4 is a weighted average sale price. These shares were sold in multiple transactions at prices ranging from $10.80 to $11.29 inclusive. The Reporting Person undertakes to provide the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.

4. The Reporting Person is the manager of Bayview Legacy, LLC and as such is deemed to have voting and dispositive power of the shares beneficially owned by Bayview Legacy, LLC.

5. The shares are held by Charles and Lydia Janac Trust, for which the Reporting Person serves as trustee.

Remarks:

	/s/ Paul Alpern, as Attorney-in-Fact for JANAC K CHARLES	10/06/2025
	** Signature of Reporting Person	Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.

FAQ

What insider transactions did Arteris (AIP) report?

Sales on 10/02/2025 of 2,767, 1,613, and 2,767 shares at $10.9208, and on 10/03/2025 of 11,821 shares at a weighted average $11.0705.

Were the Arteris (AIP) insider sales under a 10b5-1 plan?

Yes. One transaction was made pursuant to a Rule 10b5‑1 trading plan adopted on March 5, 2025.

Why were some Arteris (AIP) shares sold by the insider?

Footnotes state shares were sold to satisfy the reporting person’s tax liability from an RSU release.

What are K. Charles Janac’s holdings in Arteris (AIP) after the trades?

167,514 shares direct; 9,839,071 via Bayview Legacy, LLC; and 56,252 in the Charles and Lydia Janac Trust.

What prices were reported for the Arteris (AIP) insider sales?

Sales at $10.9208; and a weighted average of $11.0705 with trade prices from $10.80 to $11.29.

What is the insider’s role at Arteris (AIP)?

The reporting person is President and CEO, a Director, and a 10% Owner.